nodes	percent_of_prediction	percent_of_DWPC	metapath
Pindolol—ADRB3—polycystic ovary syndrome	0.603	0.724	CbGaD
Pindolol—ADRB2—polycystic ovary syndrome	0.229	0.275	CbGaD
Pindolol—Heartburn—Metformin—polycystic ovary syndrome	0.002	0.0846	CcSEcCtD
Pindolol—Lightheadedness—Metformin—polycystic ovary syndrome	0.00123	0.0521	CcSEcCtD
Pindolol—Lethargy—Metformin—polycystic ovary syndrome	0.00102	0.0431	CcSEcCtD
Pindolol—Cramp muscle—Metformin—polycystic ovary syndrome	0.000898	0.0381	CcSEcCtD
Pindolol—Nadolol—ADRB3—polycystic ovary syndrome	0.000886	0.114	CrCbGaD
Pindolol—Bupranolol—ADRB3—polycystic ovary syndrome	0.000845	0.109	CrCbGaD
Pindolol—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.000826	0.035	CcSEcCtD
Pindolol—Drowsiness—Metformin—polycystic ovary syndrome	0.000768	0.0326	CcSEcCtD
Pindolol—Bradycardia—Metformin—polycystic ovary syndrome	0.000702	0.0298	CcSEcCtD
Pindolol—Alprenolol—ADRB3—polycystic ovary syndrome	0.000648	0.0835	CrCbGaD
Pindolol—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00064	0.0271	CcSEcCtD
Pindolol—Angiopathy—Metformin—polycystic ovary syndrome	0.000626	0.0265	CcSEcCtD
Pindolol—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.000622	0.0264	CcSEcCtD
Pindolol—Flatulence—Metformin—polycystic ovary syndrome	0.000592	0.0251	CcSEcCtD
Pindolol—Muscle spasms—Metformin—polycystic ovary syndrome	0.000577	0.0245	CcSEcCtD
Pindolol—Tremor—Metformin—polycystic ovary syndrome	0.000562	0.0238	CcSEcCtD
Pindolol—Syncope—Metformin—polycystic ovary syndrome	0.000538	0.0228	CcSEcCtD
Pindolol—Palpitations—Metformin—polycystic ovary syndrome	0.000531	0.0225	CcSEcCtD
Pindolol—Loss of consciousness—Metformin—polycystic ovary syndrome	0.000528	0.0224	CcSEcCtD
Pindolol—Chest pain—Metformin—polycystic ovary syndrome	0.000511	0.0217	CcSEcCtD
Pindolol—Myalgia—Metformin—polycystic ovary syndrome	0.000511	0.0217	CcSEcCtD
Pindolol—Oedema—Metformin—polycystic ovary syndrome	0.00049	0.0208	CcSEcCtD
Pindolol—Shock—Metformin—polycystic ovary syndrome	0.000482	0.0204	CcSEcCtD
Pindolol—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00048	0.0204	CcSEcCtD
Pindolol—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000474	0.0201	CcSEcCtD
Pindolol—Hypotension—Metformin—polycystic ovary syndrome	0.000458	0.0194	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000446	0.0189	CcSEcCtD
Pindolol—Levobunolol—ADRB2—polycystic ovary syndrome	0.000445	0.0573	CrCbGaD
Pindolol—Paraesthesia—Metformin—polycystic ovary syndrome	0.00044	0.0187	CcSEcCtD
Pindolol—Dyspnoea—Metformin—polycystic ovary syndrome	0.000437	0.0185	CcSEcCtD
Pindolol—Somnolence—Metformin—polycystic ovary syndrome	0.000436	0.0185	CcSEcCtD
Pindolol—Dyspepsia—Metformin—polycystic ovary syndrome	0.000431	0.0183	CcSEcCtD
Pindolol—Isoprenaline—ADRB3—polycystic ovary syndrome	0.000428	0.0551	CrCbGaD
Pindolol—Metipranolol—ADRB2—polycystic ovary syndrome	0.000424	0.0546	CrCbGaD
Pindolol—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000423	0.0179	CcSEcCtD
Pindolol—Fatigue—Metformin—polycystic ovary syndrome	0.000422	0.0179	CcSEcCtD
Pindolol—Constipation—Metformin—polycystic ovary syndrome	0.000419	0.0178	CcSEcCtD
Pindolol—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000404	0.0171	CcSEcCtD
Pindolol—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000401	0.017	CcSEcCtD
Pindolol—Abdominal pain—Metformin—polycystic ovary syndrome	0.000387	0.0164	CcSEcCtD
Pindolol—Carteolol—ADRB2—polycystic ovary syndrome	0.000378	0.0487	CrCbGaD
Pindolol—Asthenia—Metformin—polycystic ovary syndrome	0.000352	0.0149	CcSEcCtD
Pindolol—Pruritus—Metformin—polycystic ovary syndrome	0.000347	0.0147	CcSEcCtD
Pindolol—Esmolol—ADRB2—polycystic ovary syndrome	0.000337	0.0434	CrCbGaD
Pindolol—Nadolol—ADRB2—polycystic ovary syndrome	0.000337	0.0434	CrCbGaD
Pindolol—Diarrhoea—Metformin—polycystic ovary syndrome	0.000335	0.0142	CcSEcCtD
Pindolol—Dizziness—Metformin—polycystic ovary syndrome	0.000324	0.0137	CcSEcCtD
Pindolol—Bupranolol—ADRB2—polycystic ovary syndrome	0.000321	0.0414	CrCbGaD
Pindolol—Vomiting—Metformin—polycystic ovary syndrome	0.000312	0.0132	CcSEcCtD
Pindolol—Rash—Metformin—polycystic ovary syndrome	0.000309	0.0131	CcSEcCtD
Pindolol—Dermatitis—Metformin—polycystic ovary syndrome	0.000309	0.0131	CcSEcCtD
Pindolol—Headache—Metformin—polycystic ovary syndrome	0.000307	0.013	CcSEcCtD
Pindolol—Propranolol—ADRB3—polycystic ovary syndrome	0.000304	0.0392	CrCbGaD
Pindolol—Betaxolol—ADRB2—polycystic ovary syndrome	0.000297	0.0382	CrCbGaD
Pindolol—Atenolol—ADRB2—polycystic ovary syndrome	0.000294	0.0379	CrCbGaD
Pindolol—Nausea—Metformin—polycystic ovary syndrome	0.000291	0.0123	CcSEcCtD
Pindolol—Bisoprolol—ADRB2—polycystic ovary syndrome	0.000287	0.0369	CrCbGaD
Pindolol—Acebutolol—ADRB2—polycystic ovary syndrome	0.000271	0.035	CrCbGaD
Pindolol—Oxprenolol—ADRB2—polycystic ovary syndrome	0.000269	0.0347	CrCbGaD
Pindolol—Alprenolol—ADRB2—polycystic ovary syndrome	0.000246	0.0317	CrCbGaD
Pindolol—Metoprolol—ADRB2—polycystic ovary syndrome	0.000229	0.0295	CrCbGaD
Pindolol—Isoprenaline—ADRB2—polycystic ovary syndrome	0.000163	0.0209	CrCbGaD
Pindolol—Isoprenaline—CYP1A1—polycystic ovary syndrome	0.000139	0.018	CrCbGaD
Pindolol—Propranolol—ADRB2—polycystic ovary syndrome	0.000116	0.0149	CrCbGaD
Pindolol—Propranolol—CYP1A1—polycystic ovary syndrome	9.92e-05	0.0128	CrCbGaD
Pindolol—CYP2D6—Metabolism—LPCAT2—polycystic ovary syndrome	3.15e-05	0.000232	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—SUOX—polycystic ovary syndrome	3.15e-05	0.000232	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—LHB—polycystic ovary syndrome	3.13e-05	0.000231	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PDE3B—polycystic ovary syndrome	3.08e-05	0.000227	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	3.07e-05	0.000226	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—AKR1C3—polycystic ovary syndrome	3.06e-05	0.000226	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—GNRH1—polycystic ovary syndrome	3.06e-05	0.000225	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—TNRC6B—polycystic ovary syndrome	3.02e-05	0.000222	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PDE3B—polycystic ovary syndrome	3.01e-05	0.000222	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—GHRL—polycystic ovary syndrome	3e-05	0.000221	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—PGR—polycystic ovary syndrome	2.98e-05	0.00022	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—AKR1C1—polycystic ovary syndrome	2.97e-05	0.000218	CbGpPWpGaD
Pindolol—HTR1B—GPCR downstream signaling—GNAS—polycystic ovary syndrome	2.96e-05	0.000218	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—GHRL—polycystic ovary syndrome	2.94e-05	0.000216	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—SCT—polycystic ovary syndrome	2.94e-05	0.000216	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—ISYNA1—polycystic ovary syndrome	2.93e-05	0.000215	CbGpPWpGaD
Pindolol—CYP2D6—Biological oxidations—POMC—polycystic ovary syndrome	2.92e-05	0.000215	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—ADRB2—polycystic ovary syndrome	2.9e-05	0.000213	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—FSHR—polycystic ovary syndrome	2.87e-05	0.000211	CbGpPWpGaD
Pindolol—ADRB1—GPCR ligand binding—POMC—polycystic ovary syndrome	2.81e-05	0.000207	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—FSHR—polycystic ovary syndrome	2.81e-05	0.000207	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—MTNR1B—polycystic ovary syndrome	2.8e-05	0.000206	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—GHRL—polycystic ovary syndrome	2.79e-05	0.000205	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—GHRL—polycystic ovary syndrome	2.77e-05	0.000204	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—PLAT—polycystic ovary syndrome	2.77e-05	0.000204	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—FGF18—polycystic ovary syndrome	2.75e-05	0.000203	CbGpPWpGaD
Pindolol—ADRB2—GPCR ligand binding—POMC—polycystic ovary syndrome	2.75e-05	0.000202	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—FSHR—polycystic ovary syndrome	2.74e-05	0.000202	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—RBP4—polycystic ovary syndrome	2.73e-05	0.000201	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—GHRL—polycystic ovary syndrome	2.73e-05	0.000201	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	2.7e-05	0.000199	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—GNAS—polycystic ovary syndrome	2.69e-05	0.000198	CbGpPWpGaD
Pindolol—HTR1A—GPCR ligand binding—POMC—polycystic ovary syndrome	2.69e-05	0.000198	CbGpPWpGaD
Pindolol—HTR1A—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	2.68e-05	0.000197	CbGpPWpGaD
Pindolol—ADRB3—GPCR downstream signaling—POMC—polycystic ovary syndrome	2.67e-05	0.000197	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—GHRL—polycystic ovary syndrome	2.67e-05	0.000196	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—ATF1—polycystic ovary syndrome	2.65e-05	0.000195	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	2.64e-05	0.000194	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	2.62e-05	0.000193	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.58e-05	0.00019	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	2.58e-05	0.00019	CbGpPWpGaD
Pindolol—ADRB3—GPCR downstream signaling—AKT2—polycystic ovary syndrome	2.57e-05	0.000189	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	2.57e-05	0.000189	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—FST—polycystic ovary syndrome	2.56e-05	0.000188	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—YAP1—polycystic ovary syndrome	2.55e-05	0.000188	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	2.54e-05	0.000187	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—ADRB3—polycystic ovary syndrome	2.52e-05	0.000186	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—GAB1—polycystic ovary syndrome	2.51e-05	0.000185	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—ADRA1A—polycystic ovary syndrome	2.51e-05	0.000185	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—FST—polycystic ovary syndrome	2.5e-05	0.000184	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—LHB—polycystic ovary syndrome	2.49e-05	0.000184	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—TEAD2—polycystic ovary syndrome	2.49e-05	0.000183	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—AKR1C2—polycystic ovary syndrome	2.49e-05	0.000183	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—ADRB3—polycystic ovary syndrome	2.47e-05	0.000182	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—FST—polycystic ovary syndrome	2.44e-05	0.00018	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—NGFR—polycystic ovary syndrome	2.44e-05	0.00018	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—LHB—polycystic ovary syndrome	2.44e-05	0.00018	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—GNRH1—polycystic ovary syndrome	2.44e-05	0.00018	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	2.43e-05	0.000179	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—POMC—polycystic ovary syndrome	2.43e-05	0.000179	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—PRL—polycystic ovary syndrome	2.42e-05	0.000178	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—ADRB3—polycystic ovary syndrome	2.41e-05	0.000178	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—INSR—polycystic ovary syndrome	2.4e-05	0.000177	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—LHB—polycystic ovary syndrome	2.39e-05	0.000176	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—GNRH1—polycystic ovary syndrome	2.39e-05	0.000176	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	2.36e-05	0.000174	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	2.36e-05	0.000174	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—SCT—polycystic ovary syndrome	2.34e-05	0.000172	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.33e-05	0.000172	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—GNRH1—polycystic ovary syndrome	2.33e-05	0.000172	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	2.31e-05	0.00017	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	2.31e-05	0.00017	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	2.31e-05	0.00017	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—ADRB2—polycystic ovary syndrome	2.3e-05	0.000169	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—SCT—polycystic ovary syndrome	2.29e-05	0.000168	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—AKR1C3—polycystic ovary syndrome	2.28e-05	0.000168	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	2.26e-05	0.000166	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	2.25e-05	0.000166	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—TNRC6B—polycystic ovary syndrome	2.25e-05	0.000165	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—SCT—polycystic ovary syndrome	2.24e-05	0.000165	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	2.23e-05	0.000164	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—PGR—polycystic ovary syndrome	2.22e-05	0.000164	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	2.21e-05	0.000163	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—FGF18—polycystic ovary syndrome	2.19e-05	0.000161	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	2.18e-05	0.000161	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—RBP4—polycystic ovary syndrome	2.17e-05	0.00016	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—FGF18—polycystic ovary syndrome	2.14e-05	0.000158	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—GNAS—polycystic ovary syndrome	2.14e-05	0.000158	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	2.13e-05	0.000157	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—GNAS—polycystic ovary syndrome	2.13e-05	0.000157	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—RBP4—polycystic ovary syndrome	2.13e-05	0.000157	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—FGF18—polycystic ovary syndrome	2.1e-05	0.000154	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—GNAS—polycystic ovary syndrome	2.09e-05	0.000154	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	2.08e-05	0.000153	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—RBP4—polycystic ovary syndrome	2.08e-05	0.000153	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—PLAT—polycystic ovary syndrome	2.07e-05	0.000152	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—GHRL—polycystic ovary syndrome	2.07e-05	0.000152	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—GNAS—polycystic ovary syndrome	2.05e-05	0.000151	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.03e-05	0.000149	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—YAP1—polycystic ovary syndrome	2.03e-05	0.000149	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—GAB1—polycystic ovary syndrome	2e-05	0.000147	CbGpPWpGaD
Pindolol—HTR1B—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.99e-05	0.000147	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—NRG1—polycystic ovary syndrome	1.99e-05	0.000147	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—YAP1—polycystic ovary syndrome	1.98e-05	0.000146	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	1.98e-05	0.000146	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—ATF1—polycystic ovary syndrome	1.97e-05	0.000145	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—GAB1—polycystic ovary syndrome	1.96e-05	0.000144	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—YAP1—polycystic ovary syndrome	1.94e-05	0.000143	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.92e-05	0.000142	CbGpPWpGaD
Pindolol—HTR1B—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.92e-05	0.000141	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—GAB1—polycystic ovary syndrome	1.91e-05	0.000141	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—INSR—polycystic ovary syndrome	1.91e-05	0.000141	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	1.88e-05	0.000139	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—INSR—polycystic ovary syndrome	1.87e-05	0.000138	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—INSR—polycystic ovary syndrome	1.83e-05	0.000135	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—NGFR—polycystic ovary syndrome	1.82e-05	0.000134	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.82e-05	0.000134	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—POMC—polycystic ovary syndrome	1.81e-05	0.000133	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—PRL—polycystic ovary syndrome	1.8e-05	0.000133	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.79e-05	0.000132	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.78e-05	0.000131	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PGR—polycystic ovary syndrome	1.77e-05	0.00013	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.75e-05	0.000129	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.74e-05	0.000128	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.74e-05	0.000128	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PGR—polycystic ovary syndrome	1.73e-05	0.000128	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.71e-05	0.000126	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.71e-05	0.000126	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—IRS2—polycystic ovary syndrome	1.71e-05	0.000126	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PGR—polycystic ovary syndrome	1.69e-05	0.000125	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	1.68e-05	0.000124	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—LEP—polycystic ovary syndrome	1.67e-05	0.000123	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PLAT—polycystic ovary syndrome	1.65e-05	0.000121	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—GHRL—polycystic ovary syndrome	1.65e-05	0.000121	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PLAT—polycystic ovary syndrome	1.61e-05	0.000119	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—GHRL—polycystic ovary syndrome	1.61e-05	0.000119	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	1.6e-05	0.000118	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—GNAS—polycystic ovary syndrome	1.59e-05	0.000117	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.59e-05	0.000117	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PLAT—polycystic ovary syndrome	1.58e-05	0.000116	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—GHRL—polycystic ovary syndrome	1.58e-05	0.000116	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—ATF1—polycystic ovary syndrome	1.57e-05	0.000116	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.55e-05	0.000114	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—ATF1—polycystic ovary syndrome	1.54e-05	0.000113	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.53e-05	0.000113	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.53e-05	0.000112	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.52e-05	0.000112	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.51e-05	0.000111	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—ATF1—polycystic ovary syndrome	1.5e-05	0.000111	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.5e-05	0.00011	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.49e-05	0.00011	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—IRS1—polycystic ovary syndrome	1.49e-05	0.00011	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—NRG1—polycystic ovary syndrome	1.48e-05	0.000109	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.47e-05	0.000108	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	1.46e-05	0.000108	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.46e-05	0.000107	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—NGFR—polycystic ovary syndrome	1.45e-05	0.000107	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—POMC—polycystic ovary syndrome	1.44e-05	0.000106	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PRL—polycystic ovary syndrome	1.44e-05	0.000106	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—POMC—polycystic ovary syndrome	1.43e-05	0.000106	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	1.43e-05	0.000105	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—INS—polycystic ovary syndrome	1.43e-05	0.000105	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—NGFR—polycystic ovary syndrome	1.42e-05	0.000104	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—POMC—polycystic ovary syndrome	1.41e-05	0.000104	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PRL—polycystic ovary syndrome	1.41e-05	0.000104	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—NGFR—polycystic ovary syndrome	1.39e-05	0.000102	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.38e-05	0.000102	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	1.38e-05	0.000102	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—IGF1—polycystic ovary syndrome	1.38e-05	0.000102	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—AKT2—polycystic ovary syndrome	1.38e-05	0.000102	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—POMC—polycystic ovary syndrome	1.38e-05	0.000101	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PRL—polycystic ovary syndrome	1.37e-05	0.000101	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.36e-05	0.0001	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.35e-05	9.98e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.32e-05	9.76e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.31e-05	9.65e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.3e-05	9.6e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	1.27e-05	9.38e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—IRS2—polycystic ovary syndrome	1.27e-05	9.36e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—GNAS—polycystic ovary syndrome	1.26e-05	9.31e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—LEP—polycystic ovary syndrome	1.24e-05	9.16e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—GNAS—polycystic ovary syndrome	1.24e-05	9.11e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	1.23e-05	9.08e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—GNAS—polycystic ovary syndrome	1.21e-05	8.9e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.2e-05	8.87e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	1.19e-05	8.75e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—NRG1—polycystic ovary syndrome	1.18e-05	8.71e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.18e-05	8.68e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—NRG1—polycystic ovary syndrome	1.16e-05	8.52e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.15e-05	8.48e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	1.14e-05	8.41e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—NRG1—polycystic ovary syndrome	1.13e-05	8.33e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	1.13e-05	8.31e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—IRS1—polycystic ovary syndrome	1.11e-05	8.17e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—POMC—polycystic ovary syndrome	1.07e-05	7.87e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	1.07e-05	7.84e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—INS—polycystic ovary syndrome	1.06e-05	7.83e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—IL6—polycystic ovary syndrome	1.05e-05	7.77e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	1.05e-05	7.72e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—IGF1—polycystic ovary syndrome	1.03e-05	7.57e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—AKT2—polycystic ovary syndrome	1.03e-05	7.57e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—IRS2—polycystic ovary syndrome	1.01e-05	7.46e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—LEP—polycystic ovary syndrome	9.91e-06	7.3e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—IRS2—polycystic ovary syndrome	9.9e-06	7.29e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	9.76e-06	7.19e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—LEP—polycystic ovary syndrome	9.69e-06	7.14e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—IRS2—polycystic ovary syndrome	9.68e-06	7.13e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—LEP—polycystic ovary syndrome	9.48e-06	6.98e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—TH—polycystic ovary syndrome	9.07e-06	6.68e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—VEGFA—polycystic ovary syndrome	9.01e-06	6.64e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—IRS1—polycystic ovary syndrome	8.84e-06	6.51e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	8.83e-06	6.5e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—IRS1—polycystic ovary syndrome	8.65e-06	6.37e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—POMC—polycystic ovary syndrome	8.51e-06	6.27e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—INS—polycystic ovary syndrome	8.46e-06	6.23e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—IRS1—polycystic ovary syndrome	8.45e-06	6.23e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—POMC—polycystic ovary syndrome	8.33e-06	6.13e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	8.3e-06	6.11e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—INS—polycystic ovary syndrome	8.28e-06	6.1e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—IGF1—polycystic ovary syndrome	8.19e-06	6.03e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—AKT2—polycystic ovary syndrome	8.18e-06	6.03e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—POMC—polycystic ovary syndrome	8.14e-06	6e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—INS—polycystic ovary syndrome	8.1e-06	5.96e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—IGF1—polycystic ovary syndrome	8.01e-06	5.9e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—AKT2—polycystic ovary syndrome	8e-06	5.89e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—IL6—polycystic ovary syndrome	7.86e-06	5.79e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—IGF1—polycystic ovary syndrome	7.83e-06	5.77e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—AKT2—polycystic ovary syndrome	7.83e-06	5.76e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	7.78e-06	5.73e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	7.61e-06	5.6e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	7.44e-06	5.48e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	7.41e-06	5.45e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	7.06e-06	5.2e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.71e-06	4.95e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	6.69e-06	4.93e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—IL6—polycystic ovary syndrome	6.26e-06	4.61e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	6.24e-06	4.59e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—IL6—polycystic ovary syndrome	6.23e-06	4.59e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—IL6—polycystic ovary syndrome	6.12e-06	4.51e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—IL6—polycystic ovary syndrome	5.99e-06	4.41e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.35e-06	3.94e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.23e-06	3.85e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.12e-06	3.77e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	5.06e-06	3.72e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	4.99e-06	3.67e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—INS—polycystic ovary syndrome	4.96e-06	3.65e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—IL6—polycystic ovary syndrome	4.64e-06	3.42e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—IL6—polycystic ovary syndrome	3.7e-06	2.72e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—IL6—polycystic ovary syndrome	3.62e-06	2.66e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—IL6—polycystic ovary syndrome	3.54e-06	2.61e-05	CbGpPWpGaD
